Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Raffaella Giambalvo"'
Autor:
Edmund Poon, Michelle Morrow, Wenjia Liao, Neil Brewis, Matthew Lakins, Emma McConnell, Quincy Kaka, Jennifer Ofoedu, Cristian Gradinaru, Raffaella Giambalvo, Miguel Gaspar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6ac30b0871634a06a45208d28f7d39c7
Autor:
Neil Brewis, Mihriban Tuna, Daniel Gliddon, Sarah Batey, Francisca Wollerton, Sylwia Marshall, Emma Goodman, Robert Hughes, Jose Munoz-Olaya, Raffaella Giambalvo, Alexander Koers, Matthew A. Lakins
All supplementary figures and tables within one powerpoint document
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3070659b0734f48b4b975e2697318a53
https://doi.org/10.1158/1078-0432.22475988
https://doi.org/10.1158/1078-0432.22475988
Autor:
Neil Brewis, Mihriban Tuna, Daniel Gliddon, Sarah Batey, Francisca Wollerton, Sylwia Marshall, Emma Goodman, Robert Hughes, Jose Munoz-Olaya, Raffaella Giambalvo, Alexander Koers, Matthew A. Lakins
Purpose:With the increased prevalence in checkpoint therapy resistance, there remains a significant unmet need for additional therapies for patients with relapsing or refractory cancer. We have developed FS222, a bispecific tetravalent antibody targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac243270a7bb28aa772748816090a7f
https://doi.org/10.1158/1078-0432.c.6529251
https://doi.org/10.1158/1078-0432.c.6529251
Autor:
Jose Munoz-Olaya, Sarah Batey, Raffaella Giambalvo, Alexander Koers, Mihriban Tuna, Matthew Lakins, Sylwia Marshall, Neil Brewis, Robert M. Hughes, Francisca Wollerton, Daniel Gliddon, Emma Goodman
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(15)
Purpose: With the increased prevalence in checkpoint therapy resistance, there remains a significant unmet need for additional therapies for patients with relapsing or refractory cancer. We have developed FS222, a bispecific tetravalent antibody targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32090e8cd495982b5484e24855f2f46b
https://pubmed.ncbi.nlm.nih.gov/32345647
https://pubmed.ncbi.nlm.nih.gov/32345647
Autor:
Cristian Gradinaru, Sylwia Marshall, Michelle Morrow, Sarah Batey, Robert M. Hughes, Neil Brewis, Raffaella Giambalvo, Mateusz Wydro, Daniel R. Gliddon, Alexander Koers, Matthew Lakins
Publikováno v:
Cancer Research. 80:4547-4547
Background Activating T cells via clustering tumour necrosis factor receptor superfamily (TNFRSF) has shown promise in cancer therapy. This has typically been achieved by crosslinking of targeting antibodies via Fc-gamma receptor (FcγR). TNFRSF memb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe3076fc822624c692fe62cf3a7f70c7
https://doi.org/10.1158/1538-7445.am2020-4547
https://doi.org/10.1158/1538-7445.am2020-4547
Autor:
Matthew A. Lakins, Alexander Koers, Jose Munoz Olaya, Raffaella Giambalvo, Daniel Jones, Sarka Pechouckova, Emma Goodman, Sylwia Marshall, Mateusz Wydro, Cristian Gradinaru, Francisca Wollerton, Sarah Batey, Daniel Gliddon, Michael Davies, Michelle Morrow, Mihriban Tuna, Neil Brewis
Publikováno v:
Cancer Research. 79:1540-1540
PD-1/L1 immune checkpoint blockade shows durable responses and extends overall survival in a subset of cancer patients. Tumour Necrosis Factor Receptor (TNFR) activation is being tested clinically to improve patient responses. However, low affinity F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca01bd12234d73ae8756bd32be0d91c
https://doi.org/10.1158/1538-7445.am2019-1540
https://doi.org/10.1158/1538-7445.am2019-1540
Autor:
S. Pechouckova, Emma Goodman, Mihriban Tuna, Michelle Morrow, Jose Munoz-Olaya, A. Knudsen, C. Gradinaru, Daniel Gliddon, Simon J. Marshall, Neil Brewis, Alexander Koers, Matthew Lakins, Deborah A. Jones, Raffaella Giambalvo, Carrie L. Hall, Sarah Batey, M. Davies, Mateusz Wydro, Francisca Wollerton, N. Masque Soler
Publikováno v:
Annals of Oncology. 29:x30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4559551309513b0cbe2cfd654b5a4b55
https://doi.org/10.1093/annonc/mdy487.014
https://doi.org/10.1093/annonc/mdy487.014